Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
BOSTON and CARLSBAD, Calif., March 15, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ: IONS)...
-
Бостон и Карлсбад, March 06, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (биржевый символ NASDAQ:AKCA), подразделение Ionis Pharmaceuticals, Inc., и Ionis Pharmaceuticals, Inc. (NASDAQ: IONS),...
-
BOSTON, Massachusetts, y CARLSBAD, California, March 06, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics , Inc. (NASDAQ: AKCA), una filial de Ionis Pharmaceuticals, Inc., e Ionis Pharmaceuticals, Inc....
-
BOSTON, Mass. E CARLSBAD, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), una società affiliata di Ionis Pharmaceuticals, Inc., e Ionis Pharmaceuticals,...
-
BOSTON, Massachusetts und CARLSBAD, Kalifornien, March 06, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), ein Tochterunternehmen von Ionis Pharmaceuticals, Inc. und Ionis...
-
BOSTON, Massachusetts et CARLSBAD, Californie, 06 mars 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ : AKCA), filiale d’Ionis Pharmaceuticals, Inc., et Ionis Pharmaceuticals,...
-
BOSTON, Mass. en CARLSBAD, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), een gelieerde onderneming van Ionis Pharmaceuticals, Inc., en Ionis Pharmaceuticals,...
-
BOSTON, Mass. and CARLSBAD, Calif., March 01, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ:...
-
BOSTON, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with...
-
TEGSEDI™ (inotersen) commercially available in United States, European Union & Canada Achieved Fourth Quarter 2018 TEGSEDI® (inotersen) Global Net Product Revenues of $2.2 Million Conference...